Dry Powder Inhalers (DPI)

In this paper the innovative approach of Nano into micro (NiM9 was developed to produce Nanoparticles loaded Ivacaftor to incorporate...

Repurposing drugs such as the FDA-approved niclosamide is a highly efficient way to leverage drugs with known safety profiles to...

Respiratory diseases account for a very significant portion of worldwide morbidity and mortality but to-date only a limited number of...

Although dry powder inhalers (DPIs) have attracted great interest compared to nebulizers and metered-dose inhalers (MDIs), drug deposition in the...

Building on a long and well established history of supplying world class pharmaceutical grade lactose, film coatings, and tableting systems,...

This study describes the development and characterization of glucagon dry powder inhaler (DPI) formulation for pulmonary delivery. Lactose monohydrate, as...

Spray drying biologics and small-molecule drugs can increase their thermal stability relative to liquid dosage forms and allow for widespread...

Non-cystic fibrosis bronchiectasis (NCFB) is a chronic respiratory disease associated with the high morbidity and mortality. Long-term intermittent therapy by...

Choice of carrier can have a significant impact on the capsule filling process as well as the performance of the...

In this video you learn more about Armor Pharma's Lactose production and solutions offered. More on Armor Pharma